While plasma CatD could differentiate NASH from steatosis, there was no difference in ALT concentrations between livers with NASH and steatosis, indicating that CatD correlates better with the spectrum of NAFLD than ALT. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.